Screening of novel excipients for improving the stability of retroviral and adenoviral vectors

Biotechnology Progress

Volumn 22, Issue 2, 2006, Pages 568-576

  Cruz, Pedro E ^a   Silva, Ana Carina ^a   Roldão, António ^a   Carmo, Marlene ^a   Carrondo, Manuel J T ^a,b   Alves, Paula M ^a  

^a INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC ENGINEERING; PH EFFECTS; STABILIZATION; VIRUSES;

ADENOVIRAL VECTORS; GENE THERAPY; LYOPHILIZATION; VIRAL VECTORS;

BIOTECHNOLOGY;

ADENOVIRUS; ARTICLE; CELL LINE; DNA DENATURATION; GENE VECTOR; GENETICS; HUMAN; RETROVIRUS; SOLUTION AND SOLUBILITY; TEMPERATURE;

ADENOVIRIDAE; CELL LINE; GENETIC VECTORS; HUMANS; NUCLEIC ACID DENATURATION; RETROVIRIDAE; SOLUTIONS; TEMPERATURE;

ADENOVIRIDAE;

EID: 33646066281     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp050294y     Document Type: Article

References (34)

1. McTaggart, S.; Al-Rubeai, M. Retroviral vectors for human gene delivery. Biotechnol. Adv. 2002, 20 (1), 1-31.
2. Nadeau, I.; Kamen, A. Production of adenovirus vector for gene therapy. Biotechnol. Adv. 2003, 20 (7-8), 475-489.
3. Robbins, P. D.1 Ghivizzani, S. C. Viral vectors for gene therapy. Pharmacol. Ther. 1998, 80 (1), 35-47.
4. Le Doux, J. M.; Davis, H. E.; Morgan, J. R.; Yarmush, M. L. Kinetics of retrovirus production and decay. Biotechnol. Bioeng. 1999, 63 (6), 654-662.
5. Croyle, M. A.; Cheng, X.; Wilson, J. M. Development of formulations that enhance physical stability of viral vectors for gene therapy. Gene Ther. 2001, 8 (17), 1281-1290.
6. Nyberg-Hoffman, C.; Aguilar-Cordova, E. Instability of adenoviral vectors during transport and its implication for clinical studies. Nat. Med. 1999, 5 (8), 955-957.
7. Obenauer-Kutner, L. J.; Ihnat, P. M.; Yang, T. Y.; Dovey-Hartman, B. J.; Balu, A.; Cullen, C.; Bordens, R. W.; Grace, M. J. The use of field emission scanning electron microscopy to assess recombinant adenovirus stability. Hum. Gene Ther. 2002, 13 (14), 1687-1696.
8. Harris, R. J. C. The preservation of viruses. In Biological Applications of Freezing and Drying; Harris, R. J. C., Ed.; Academic Press: New York, 1954; pp 201-214.
9. Greiff, D. Stabilities of suspensions of influenza virus dried by sublimation of ice in vacuo to different contents of residual moisture and sealed under different gases. Appl. Microbiol. 1970, 20 (6), 935-893.
10. Bieganski, R. M.; Fowler, A.; Morgan, J. R.; Toner, M. Stabilization of active recombinant retroviruses in an amorphous dry state with trehalose. Biotechnol. Prog. 1998, 14 (4), 615-620.
11. Evans, R. K.; Nawrocki, D. K.; Isopi, L. A.; Williams, D. M.; Casimiro, D. R.; Chin, S.; Chen, M.; Zhu, D. M.; Shiver, J. W.; Volkin, D. B. Development of stable liquid formulations for adenovirus-based vaccines. J. Pharm. Sci. 2004, 93 (10), 2458-2475.
12. Croyle, M. A.; Roessler, B. J.; Davidson, B. L.; Hilfinger, J. M.; Amidon, G. L. Factors that influence stability of recombinant adenoviral preparations for human gene therapy. Pharm. Dev. Technol. 1998, 3 (3), 373-383.
13. Crowe, L. M.; Mouradian, R.; Crowe, J. H.; Jackson, S. A.; Womersley, C. Effects of carbohydrates on membrane stability at low water activities. Biochim. Biophys. Acta 1984, 769 (1), 141-150.
14. Crowe, J. H.; Crowe, L. M.; Carpenter, J. F.; Rudolph, A. S.; Wistrom, C. A.; Spargo, B. J.; Anchordoguy, T. J. Interactions of sugars with membranes. Biochim. Biophys. Acta 1988, 947 (2), 367-384.
15. Leslie, S. B.; Israeli, E.; Lighthart, B.; Crowe, J. H.; Crowe, L. M. Trehalose and sucrose protect both membranes and proteins in intact bacteria during drying. Appl. Environ. Microbiol. 1995, 61 (10), 3592-3597.
16. Carpenter, J. F.; Crowe, J. H. The mechanism of cryoprotection of proteins by solutes. Cryobiology 1988, 25 (3), 244-255.
17. Mi, Y. Protection mechanisms of excipients on lactate dehydrogenase during freeze-thawing and lyophilization. Doctoral Dissertation, The University of Tennessee, 2002.
18. Anchordoguy, T. J.; Rudolph, A. S.; Carpenter, J. F.; Crowe, J. H. Modes of interaction of cryoprotectants with membrane phospholipids during freezing. Cryobiology 1987, 24 (4), 324-331.
19. Miyajima, K.; Tomita, K.; Nakagaki, M. Effect of saccharides on the freezing and thawing of liposome dispersion. Chem. Pharm. Bull. (Tokyo) 1986, 34 (7), 2689-2697.
20. Strauss, G.; Schurtenberger, P.; Hauser, H. The interaction of saccharides with lipid bilayer vesicles: stabilization during freeze-thawing and freeze-drying. Biochim. Biophys. Acta 1986, 858 (1), 169-180.
21. Santos, H.; Costa, M. d. Compatible solutes of organisms that live in hot saline environments. Environ. Microbiol. 2002, 4 (9), 501-509.
22. Martins, L. O.; Santos, H. Accumulation of mannosylglycerate and di-myo-inositol-phosphate by Pyrococcus furiosus in response to salinity and temperature. Appl. Environ. Microbiol. 1995, 61, 3299-3303.
23. Borges, N.; Ramos, A.; Raven, N. D.; Sharpen, R. J. Comparative study of the thermostabilizing properties of mannosylglycerate and other compatible solutes on model enzymes. Extremophiles 2002, 6 (3), 209-216.
24. Carmo, M.; Peixoto, C.; Coroadinha, A. S.; Alves, P. M.; Cruz, P. E.; Carrondo, M. J. Quantitation of MLV-based retroviral vectors using real-time RT-PCR. J. Virol. Methods 2004, 119 (2), 115-119.
25. Graham, F. L.; Smiley, J.; Russell, W. C.; Nairn, R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 1977, 36 (1), 59-74.
26. Graham, F. L.; van der Eb, A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973, 52 (2), 456-467.
27. Kotani, H.; Newton, P. B., 3rd; Zhang, S.; Chiang, Y. L.; Otto, E.; Weaver, L.; Blaese, R. M.; Anderson, W. F.; McGarrity, G. J. Improved methods of retroviral vector transduction and production for gene therapy. Hum. Gene Ther. 1994, 5 (1), 19-28.
28. Darling, A. J.; Boose, J. A.; Spaltro, J. Virus assay methods: accuracy and validation. Biologicals 1998, 26 (2), 105-110.
29. Cruz, P. E.; Almeida, J. S.; Murphy, P. N.; Moreira, J. L.; Carrondo, M. J. Modeling retrovirus production for gene therapy. 1. Determination Of optimal bioreaction mode and harvest strategy. Biotechnol. Prog. 2000, 16 (2), 213-221.
30. Merten, O. W.; Cruz, P. E.; Rochette, C.; Geny-Fiamma, C.; Bouquet, C.; Goncalves, D.; Danos, O.; Carrondo, M. J. Comparison of different bioreactor systems for the production of high titer retroviral vectors. Biotechnol. Prog. 2001, 17 (2), 326-335.
31. Lee, S. G.; Kim, S.; Robbins, P. D.; Kim, B. G. Optimization of environmental factors for the production and handling of recombinant retrovirus. Appl. Microbiol. Biotechnol. 1996, 45 (4), 477-483.
32. Murase, N.; Franks, F. Salt precipitation during the freeze-concentration of phosphate buffer solutions. Biophys. Chem. 1989, 34 (3), 293-300.
33. Hoganson, D. K.; MA, J. C.; Asato, L.; Ong, M.; Printz, M. A.; Huyghe, B. G.; Sosnowski, B. A.; D'Andrea, M. J. Development of a stable adenoviral vector formulation. Bioprocess. J. 2002, 1, (1), 43-48.
34. Shuyuan, Z.; Zheng, W. Formulation of adenovirus for gene therapy. 2000-05-25, 2000.